These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27833404)

  • 1. Transcatheter Arterial Chemoembolization Plus
    Zhu ZX; Liao MH; Wang XX; Huang JW
    Korean J Radiol; 2016; 17(6):882-892. PubMed ID: 27833404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial chemoembolization plus iodine-125 implantation for hepatocellular carcinoma: a systematic review and meta-analysis.
    Zhu ZX; Wang XX; Yuan KF; Huang JW; Zeng Y
    HPB (Oxford); 2018 Sep; 20(9):795-802. PubMed ID: 29779970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Huo YR; Eslick GD
    JAMA Oncol; 2015 Sep; 1(6):756-65. PubMed ID: 26182200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma.
    Yang DJ; Luo KL; Liu H; Cai B; Tao GQ; Su XF; Hou XJ; Ye F; Li XY; Tian ZQ
    Oncotarget; 2017 Jan; 8(2):2960-2970. PubMed ID: 27936465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma.
    He Q; Lu WS; Liu Y; Guan YS; Kuang AR
    World J Gastroenterol; 2013 Dec; 19(47):9104-10. PubMed ID: 24379637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of the efficacy and safety of iodine [
    Fan W; Wu Y; Lu M; Yao W; Cui W; Zhao Y; Wang Y; Li J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):451-459. PubMed ID: 30348520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.
    Ni JY; Liu SS; Xu LF; Sun HL; Chen YT
    World J Gastroenterol; 2013 Jun; 19(24):3872-82. PubMed ID: 23840128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 131I-Labeled-Metuximab Plus Transarterial Chemoembolization in Combination Therapy for Unresectable Hepatocellular Carcinoma: Results from a Multicenter Phase IV Clinical Study.
    Ma J; Wang JH
    Asian Pac J Cancer Prev; 2015; 16(17):7441-7. PubMed ID: 26625741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis.
    Cao DD; Xu HL; Liu L; Zheng YF; Gao SF; Xu XM; Ge W
    Oncotarget; 2017 Jul; 8(27):44976-44993. PubMed ID: 28402958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Artery Injection of
    Chen H; Nan G; Wei D; Zhai RY; Huang M; Yang WW; Xing BC; Zhu X; Xu HF; Wang XD; Zhang XY; Zhu BR; Liu P; Cao G; Gao S; Hao CY; Yang RJ; Guo JH; Zhang X; Gao K; Wang K; Wang JF; Li ZY; Zhu LZ; Ding R; Li J; Zhao L; Shao YJ; Liu HC; Xia JL; Wang L; Kong LM; Chen ZN; Bian H
    J Nucl Med; 2022 Apr; 63(4):556-559. PubMed ID: 34475235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic artery injection of ¹³¹I-labelled metuximab combined with chemoembolization for intermediate hepatocellular carcinoma: a prospective nonrandomized study.
    Wu L; Yang YF; Ge NJ; Shen SQ; Liang J; Wang Y; Zhou WP; Shen F; Wu MC
    Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1306-15. PubMed ID: 22588627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide Combined with Transcatheter Arterial Chemoembolization (TACE) for Intermediate or Advanced Hepatocellular Carcinoma: A Systematic Review and GRADE Approach.
    Yang W; Wang D; Huang L; Chen Y; Wen S; Hong Q; Kang D
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2043-2055. PubMed ID: 30139041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical value of iodine [131I] metuximab infusion combined with TACE for treatment of patients with post-intervention relapse of mid or advanced stage hepatocellular carcinoma].
    Li Z; Zhou JX; Ren JZ; Zhang WJ; Han XW
    Zhonghua Gan Zang Bing Za Zhi; 2013 Oct; 21(10):728-33. PubMed ID: 24331628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Zou LQ; Zhang BL; Chang Q; Zhu FP; Li YY; Wei YQ; Guan YS
    World J Gastroenterol; 2014 Dec; 20(45):17227-34. PubMed ID: 25493039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials.
    Lu Z; Wen F; Guo Q; Liang H; Mao X; Sun H
    Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):187-94. PubMed ID: 23134976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Review and Meta-analysis of Endostar Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone for Hepatocellular Carcinoma.
    Zhang YQ; Zhao F; Song L; Gan HY; Xie XF
    J Evid Based Complementary Altern Med; 2017 Oct; 22(4):883-891. PubMed ID: 29228810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Transcatheter Arterial Chemoembolization and Transcatheter Arterial Chemotherapy Infusion in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Liu X; Wang Z; Chen Z; Liu L; Ma L; Dong L; Zhang Z; Zhang S; Yang L; Shi J; Fan J; Wang X; Gao Q
    Oncol Res; 2018 Mar; 26(2):231-239. PubMed ID: 28911342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Wang W; Shi J; Xie WF
    Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
    Li L; Zhao W; Wang M; Hu J; Wang E; Zhao Y; Liu L
    BMC Gastroenterol; 2018 Sep; 18(1):138. PubMed ID: 30180810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: A systematic review and meta-analysis.
    Chen QW; Ying HF; Gao S; Shen YH; Meng ZQ; Chen H; Chen Z; Teng WJ
    Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):309-314. PubMed ID: 26428660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.